Interaction of Nanoparticles with Immunocompetent Cells: Nanosafety Considerations
- 22 December 2011
- journal article
- review article
- Published by Taylor & Francis in Nanomedicine
- Vol. 7 (1) , 121-131
Abstract
Intentional delivery of high doses of nanoparticle-based drugs or diagnostic/imaging systems sets a new scenario in safety evaluation, compared with the environmentally borne unintentional exposure...Keywords
This publication has 60 references indexed in Scilit:
- Enzymatic Degradation of Multiwalled Carbon NanotubesThe Journal of Physical Chemistry A, 2011
- Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1βProceedings of the National Academy of Sciences, 2010
- Complement control protein factor H: The good, the bad, and the inadequateMolecular Immunology, 2010
- Update on Biology: Uric Acid and the Activation of Immune and Inflammatory CellsCurrent Rheumatology Reports, 2010
- Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?Trends in Immunology, 2010
- NETs: a new strategy for using old weaponsTrends in Immunology, 2009
- Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearanceBiomaterials, 2009
- Immunocompatibility properties of lipid–polymer hybrid nanoparticles with heterogeneous surface functional groupsBiomaterials, 2009
- A Prescription for Human ImmunologyImmunity, 2008
- Nanoparticle size and surface properties determine the protein corona with possible implications for biological impactsProceedings of the National Academy of Sciences of the United States of America, 2008